These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 8907566)

  • 1. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
    Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
    J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
    Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
    Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.
    Lancet; 1998 May; 351(9115):1535-9. PubMed ID: 10326535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis.
    Gramenzi A; Andreone P; Fiorino S; Cammà C; Giunta M; Magalotti D; Cursaro C; Calabrese C; Arienti V; Rossi C; Di Febo G; Zoli M; Craxì A; Gasbarrini G; Bernardi M
    Gut; 2001 Jun; 48(6):843-8. PubMed ID: 11358906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
    Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
    Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G; Giustina G; Degos F; Diodati G; Tremolada F; Nevens F; Almasio P; Solinas A; Brouwer JT; Thomas H; Realdi G; Corrocher R; Schalm SW
    J Hepatol; 1997 Jul; 27(1):201-5. PubMed ID: 9252096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.
    Ikeda K; Saitoh S; Kobayashi M; Suzuki Y; Suzuki F; Tsubota A; Arase Y; Murashima N; Chayama K; Kumada H
    J Gastroenterol Hepatol; 2001 Apr; 16(4):406-15. PubMed ID: 11354279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.
    Cheinquer N; Cheinquer H; Wolff FH; Coelho-Borges S
    Braz J Infect Dis; 2010; 14(5):457-61. PubMed ID: 21221473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
    Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
    Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey.
    Bonino F; Oliveri F; Colombatto P; Brunetto MR
    J Viral Hepat; 1997; 4 Suppl 2():79-82. PubMed ID: 9429213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can interferon prevent hepatocellular carcinoma in hepatitis C virus-induced cirrhosis?
    Grimm I; Shaheen N
    Gastroenterology; 1996 Jun; 110(6):2019-21. PubMed ID: 8964437
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.
    Baffis V; Shrier I; Sherker AH; Szilagyi A
    Ann Intern Med; 1999 Nov; 131(9):696-701. PubMed ID: 10577333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.
    Naoumov NV; Chokshi S; Metivier E; Maertens G; Johnson PJ; Williams R
    J Hepatol; 1997 Aug; 27(2):331-6. PubMed ID: 9288608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
    Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
    Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.